Newsletters
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
CDC-FDA webinar: Developing drugs to prevent healthcare-associated infections (30 Aug 2022)
Dear All, A quick note today to call your attention to an upcoming webinar that will be of wide interest. …
US Senate and House / Call for Pull incentives in FY23 budget
Dear All, The US Government is now building its budget for FY23 (Federal Year 2023, really runs 1 Oct 22 …
WHO Vaccine pipeline review; CDC on impact of COVID on AMR
Dear All, WHO continues to crank out those pipeline reviews … now we have one for bacterial vaccines! Go here …
IDWeek 2022: New pipeline sessions seek presentation of therapeutics and diagnostics!
Dear All: I have learned that the program for IDWeek 2022 will have specific dedicated pipeline sessions for therapeutics and …
Leaky pipe(line)s, Part 2 / CARB-X reboot / WHO 2021 pipeline review
Dear All, We have a 3-part discussion today on the theme of “I want a new drug … so how …
Antibiotic procurement models for LMICs / G7 Leaders call for Pull!
Dear All, Two stops on our tour today: (i) an excellent survey of incentive models and (ii) a final communique …
Leaky pipe(lines) / When is a molecule a drug? (Part 1 of 2)
Dear All, I was fascinated by this recent paper in AAC: Neha K. Prasad, Ian B. Seiple, Ryan T. Cirz, …
FDA/CVM: Antimicrobial use in companion animals
Dear All, Post-newsletter addendum: I’ve learned that USDA will host a 10 Aug 2022 (virtual, 10a-4.30p ET) workshop on AMR in …
ATMF on Access in LMICs/Progress, but wishing for more
Dear All, Last fall, the team at ATMF (Access to Medicine Foundation) released the 3rd update to the AMR Benchmark …
Climate change and AMR: NIH grant opportunity!
Dear All, A Notice of Special Interest (a “NOSI” in NIH jargon; here’s the link: NOT-ES-22-006) from the NIH could be …
Notable reports: Incentives (WHO, AMR Hub); Strategy (BARDA); Capacity Building (UK Fleming Fund, US CDC)
Dear All, Four big reports have recently been released and are very much worth reviewing. First, the Global AMR R&D …
Antibacterial guidance (including pediatrics): Parallel EMA+FDA updates
Dear All (Wonkish alert! Get some coffee and settle in!), Almost in parallel, EMA and FDA have released updates to …
G7 Health Ministers: Pull incentives to support stewardship, access, and innovation
Dear All, The G7 Health Ministers met 19-20 May 2022 in Berlin. As you might expect, their communique covered a …
CARB-X renewed x 10 years! Strong calls for PASTEUR!
Dear All, On the heels of yesterday’s (i) patient-focused meeting at the Capitol yesterday where 5 Members of Congress spoke …
3 June 2022 FDA workshop: Developing for uncomplicated UTI (uUTI)
Dear All, It doesn’t rain … it pours! Just seconds after sending out a newsletter on the 18 May et …
Starting 18 May: #SquashSuperbugs, Salt in My Soul (movie), and more!
Dear All, Building on last year’s call from PFID to declare 18 May the annual “Squash Superbugs Day of Action,” we …
Meetings and more: Pandemic wargames! NIAID developer workshop! New stewardship prize!
Dear All, As suggested by the subject line, this newsletter is a bit of a mish-mash of time-critical news about …
Job Opportunity In Berlin With Global AMR R&D Hub!
Dear All, The Global AMR R&D Hub is looking for Head of the Global AMR R&D Hub Secretariat! The position would be …
Antibiotic supply chains: Challenges & Opportunities
Dear All, In a report entitled Understanding the Antibiotic Manufacturing Ecosystem: A view of global supply chains, pressure points, and implications …
NIAID BAA To Support In Vitro Diagnostic Product Development
Dear All, Excitingly, NIAID has released a new BAA (Broad Agency Announcement) entitled “Diagnostics Pre-Clinical Services Program.” Similar to the prior …
